Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Longterm survival and late effects following hematopoietic cell transplantation for sickle cell disease into a modern era: A center for international blood and marrow transplant research (CIBMTR) analysis

Elizabeth Stenger, Ruta Brazauskas, Andrew Peterson, Stephanie Bo-Subait, Minoo Battiwalla, David Buchbinder, Betty K. Hamilton, Bipin Savani, Helene Schoemans, Michelle Schoettler, Mohamed Sorror, Rachel Phelan, Shalini Shenoy, Lakshmanan Krishnamurti

Blood (2025) 146 (Supplement 1): 1051.

https://doi.org/10.1182/blood-2025-1051

Published: 2025

Journal Articles

CRISPR-Cas12a gene editing of the HBG1/2 promoters leads to sustained normalization of total hemoglobin and increased fetal hemoglobin in patients with severe sickle cell disease: Updated Results from the RUBY trial

Blood (2025) 146 (Supplement 1): 4314.

https://doi.org/10.1182/blood-2025-4314

Published: 2025

Journal Articles

Children and adolescents with sickle cell disease demonstrate improved health-related quality of life and low decisional regret after hematopoietic cell transplantation: A sickle cell transplant advocacy and research alliance (STAR) study

Blood (2025) 146 (Supplement 1): 4278.

https://doi.org/10.1182/blood-2025-4278

Published: 2025

Journal Articles

Incidence and risk factors for new overweight or obesity following hematopoietic cell transplantation for sickle cell disease

Grace Kalmus, Lindsey Abel, Laurence Wechsler, Staci Arnold, Beatrice Gee, Ann Haight, Suhag Parikh, Marianne Yee, Kirshma Khemani, Elizabeth Stenger

Blood (2025) 146 (Supplement 1): 4283.

https://doi.org/10.1182/blood-2025-4283

Published: 2025

Journal Articles

Regimen Intensity and Age Affect Transplant-Related Outcomes after Matched Related Donor Hematopoietic Cell Transplantation for Sickle Cell Disease: A STAR Registry Study

Blood (2023) 142 (Supplement 1): 4904.

https://doi.org/10.1182/blood-2023-182532

Published: 2023

Journal Articles

Donor Hemoglobin Genotype Does Not Impact Outcomes Following Matched Related Donor Hematopoietic Cell Transplantation for Sickle Cell Disease: A STAR Study

Elizabeth Stenger, Tami D. John, Deepak Chellapandian, Rikin Shah, Scott Gillespie, Yijin Xiang, Katie Liu, Monica Bhatia, Gregory M.T. Guilcher, Jennifer Jaroscak, Kimberly A. Kasow, Jennifer Krajewski, Alexander I. Ngwube, Hemalatha G. Rangarajan, John T. Horan, Lakshmanan Krishnamurti, Shalini Shenoy, Allistair Abraham

Blood (2023) 142 (Supplement 1): 4955.

https://doi.org/10.1182/blood-2023-188514

Published: 2023

Journal Articles

Preliminary Results of Promis Sexual Function and Satisfaction and Perceived Risk for Infertility after Hematopoietic Cell Transplantation for Sickle Cell Disease: A Stellar Study

Lillian R Meacham, Anirudh Veludhandi, Yijin Xiang, Elizabeth Stenger, Staci D. Arnold, Akanksha Mehta, Lydia H. Pecker, Michael Hsieh, Jacqueline Y Maher, Lakshmanan Krishnamurti

Blood (2022) 140 (Supplement 1): 1397–1398.

https://doi.org/10.1182/blood-2022-163279

Published: 2022

Journal Articles

Feasibility of Using the American Time Use Survey to Study the Impact of Sickle Cell Disease and Hematopoietic Cell Transplant on the Daily Lives of Patients and Their Caregivers: A Stellar Study

Kirshma Khemani, Staci D. Arnold, Nitya Bakshi, Diana Ross, Crystal Smith, Anirban Basu, Elizabeth Stenger, Lakshmanan Krishnamurti

Blood (2022) 140 (Supplement 1): 13043–13044.

https://doi.org/10.1182/blood-2022-170685

Published: 2022

Journal Articles

Gonadal Hormone Production after Hematopoietic Cell Transplant (HCT) in Patients with Sickle Cell Disease (SCD): A Stellar Study

Sobenna A George, Anirudh Veludhandi, Yijin Xiang, Elizabeth Stenger, Staci D. Arnold, Akanksha Mehta, David A Schirmer, Jessica B Spencer, Gregory M Guilcher, Monica Bhatia, Allistair Abraham, Veronica Gomez-Lobo, Lakshmanan Krishnamurti, Lillian R Meacham

Blood (2022) 140 (Supplement 1): 1391–1392.

https://doi.org/10.1182/blood-2022-168060

Published: 2022

Journal Articles

HSC engraftment in SCD: a MiSCing piece of the puzzle?

Elizabeth Stenger

Blood (2021) 138 (24): 2451–2452.

https://doi.org/10.1182/blood.2021013535

Published: 2021

Journal Articles

Conditioning Regimens and Outcomes after Allogeneic Hematopoietic Cell Transplant for Hyperinflammatory Inborn Errors of Immunity

Rebecca A. Marsh, Soyoung Kim, Kyle Hebert, Christopher C. Dvorak, MD, Victor Aquino, MD, K. Scott Scott Baker, MD MS, Deepak Chellapandian, MD, Blachy Davila, MD, Christine Duncan, MD, Michael J. Eckrich, MD MPH, George E. Georges, MD, Timothy S. Olson, MD PhD, Michael A Pulsipher, MD, Shalini Shenoy, MD, Elizabeth Stenger, MD, Mark Vander Lugt, MD, Lolie C. Yu, MD, Andrew Gennery, MD, Mary Eapen, MBBS, MS

Blood (2020) 136 (Supplement 1): 36–37.

https://doi.org/10.1182/blood-2020-139930

Published: 2020

Journal Articles

Excellent Overall Survival and Low Incidence of Late Effects in Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Sickle Cell Disease: A Report from the Center for International Blood and Marrow Transplant Research (CIBMTR)

Elizabeth Stenger, MD, Rachel Phelan, MDMPH, Bronwen E. Shaw, MD PhD, Minoo Battiwalla, MD, Stephanie Bo-Subait, MPH, Ruta Brazauskas, PhD, David K. Buchbinder, MD MSHS, Betty K. Hamilton, MD, Shalini Shenoy, MD, Lakshmanan Krishnamurti, MD

Blood (2019) 134 (Supplement_1): 697.

https://doi.org/10.1182/blood-2019-128797

Published: 2019

Journal Articles

Immune reconstitution and survival of 100 SCID patients post–hematopoietic cell transplant: a PIDTC natural history study

Blood (2017) 130 (25): 2718–2727.

https://doi.org/10.1182/blood-2017-05-781849

Published: 2017

Includes: Supplemental data

Journal Articles

Increased Proportion of Sickle Cell Disease Patients Develop Cardiovascular Disease Risk Factors Following Successful Hematopoietic Cell Transplantation

Elizabeth Stenger, MD, Kirshma Khemani, MD, Diana Ross, MSN, RN, Lillian Meacham, MD, Courtney McCracken, PhD, Ann Haight, MD, Lakshmanan Krishnamurti, MD

Blood (2017) 130 (Supplement 1): 1999.

https://doi.org/10.1182/blood.V130.Suppl_1.1999.1999

Published: 2017

Journal Articles

Similar Event-Free Survival but Higher Incidence of Mixed T Cell Chimerism after Hematopoietic Cell Transplantation for Sickle Cell Disease Using Rabbit Versus Horse ATG: a Study from the Sickle Transplant Alliance for Research (STAR)

Allistair Abraham, MD, Elizabeth Stenger, MD, Curtis D Travers, MPH, Robert Nickel, MDMSc, Hemalatha G. Rangarajan, MD, Jennifer Krajewski, MD, Sonali Chaudhury, MBBS,MD, Kimberly A. Kasow, DO, Troy C. Quigg, DO, Alexander I. Ngwube, MD, Jennifer Jaroscak, MD, Gregory M Guilcher, MDBSc,FRCPC, Shalini Shenoy, MD, John T Horan, MD

Blood (2017) 130 (Supplement 1): 3535.

https://doi.org/10.1182/blood.V130.Suppl_1.3535.3535

Published: 2017

Journal Articles

Development of a Multi-Center Cohort to Evaluate Long-Term Outcomes and Late Effects Following Hematopoietic Cell Transplantation for Sickle Cell Disease: A STAR Initiative

Elizabeth Stenger, MD, Allistair Abraham, MD, Curtis D Travers, MPH, Hemalatha G. Rangarajan, MD, Diane Hsu, MD, Sonali Chaudhury, MBBS,MD, Kimberly A. Kasow, DO, Michael J. Eckrich, MD MPH, Alexander I. Ngwube, MD, Julie Kanter, MD, Gregory M Guilcher, MDBSc,FRCPC, John T. Horan, MDMPH, Lakshmanan Krishnamurti, MD, Shalini Shenoy, MD

Blood (2017) 130 (Supplement 1): 3271.

https://doi.org/10.1182/blood.V130.Suppl_1.3271.3271

Published: 2017

Journal Articles

CMV Viremia and African-American Ethnicity Are Risk Factors for Post-Engraftment Blood Stream Infections in Pediatric Allogeneic Blood and Marrow Transplantation

Hirozumi Sano, MD, Joseph Hilinski, MD, Kristy Applegate, MBA, Andres Camacho-Gonzalez, MD, Shanmuganathan Chandrakasan, MD, Kuang-Yueh Chiang, MD PhD, Ann Haight, MD, Lakshmanan Krishnamurti, MD, Elizabeth Stenger, MD, Muna Qayed, MD MSc, John Horan, MD MPH

Blood (2016) 128 (22): 3397.

https://doi.org/10.1182/blood.V128.22.3397.3397

Published: 2016

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Longterm survival and late effects following hematopoietic cell transplantation for sickle cell disease into a modern era: A center for international blood and marrow transplant research (CIBMTR) analysis

CRISPR-Cas12a gene editing of the HBG1/2 promoters leads to sustained normalization of total hemoglobin and increased fetal hemoglobin in patients with severe sickle cell disease: Updated Results from the RUBY trial

Children and adolescents with sickle cell disease demonstrate improved health-related quality of life and low decisional regret after hematopoietic cell transplantation: A sickle cell transplant advocacy and research alliance (STAR) study

Incidence and risk factors for new overweight or obesity following hematopoietic cell transplantation for sickle cell disease

Regimen Intensity and Age Affect Transplant-Related Outcomes after Matched Related Donor Hematopoietic Cell Transplantation for Sickle Cell Disease: A STAR Registry Study

Donor Hemoglobin Genotype Does Not Impact Outcomes Following Matched Related Donor Hematopoietic Cell Transplantation for Sickle Cell Disease: A STAR Study

Preliminary Results of Promis Sexual Function and Satisfaction and Perceived Risk for Infertility after Hematopoietic Cell Transplantation for Sickle Cell Disease: A Stellar Study

Feasibility of Using the American Time Use Survey to Study the Impact of Sickle Cell Disease and Hematopoietic Cell Transplant on the Daily Lives of Patients and Their Caregivers: A Stellar Study

Gonadal Hormone Production after Hematopoietic Cell Transplant (HCT) in Patients with Sickle Cell Disease (SCD): A Stellar Study

HSC engraftment in SCD: a MiSCing piece of the puzzle?

Conditioning Regimens and Outcomes after Allogeneic Hematopoietic Cell Transplant for Hyperinflammatory Inborn Errors of Immunity

Excellent Overall Survival and Low Incidence of Late Effects in Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Sickle Cell Disease: A Report from the Center for International Blood and Marrow Transplant Research (CIBMTR)

Immune reconstitution and survival of 100 SCID patients post–hematopoietic cell transplant: a PIDTC natural history study

Increased Proportion of Sickle Cell Disease Patients Develop Cardiovascular Disease Risk Factors Following Successful Hematopoietic Cell Transplantation

Similar Event-Free Survival but Higher Incidence of Mixed T Cell Chimerism after Hematopoietic Cell Transplantation for Sickle Cell Disease Using Rabbit Versus Horse ATG: a Study from the Sickle Transplant Alliance for Research (STAR)

Development of a Multi-Center Cohort to Evaluate Long-Term Outcomes and Late Effects Following Hematopoietic Cell Transplantation for Sickle Cell Disease: A STAR Initiative

CMV Viremia and African-American Ethnicity Are Risk Factors for Post-Engraftment Blood Stream Infections in Pediatric Allogeneic Blood and Marrow Transplantation

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only